logo
ENTITY

Medigen Biotechnology (3176 TT)

Health Care • Taiwan
Medigen Biotechnology Corp. researches and develops anti-cancer biopharmaceuticals.
more
Exchange Announcement • 24 Dec 2024 21:32

The Company Is Invited To Attend Investor Conference Held By Sinopac Securities.

Exchange Announcement • 20 Dec 2024 16:25

Medigen And Oncolys Sign An Amendment Regarding Sales Of Obp-301

Exchange Announcement • 19 Dec 2024 19:43

The Progress Update Of The New Drug Under Development, Obp-301

Exchange Announcement • 14 Dec 2024 18:25

Taiwan Mohw Has Approved A New Version Of The Collaborative Autologous Natural Killer Cell Therapy Project By The Company And Taichung Tzu Chi Hospital

Exchange Announcement • 05 Nov 2024 18:22

The Company'S 2024q3 Consolidated Financial Statements Have Been Approved By The Board Of Directors

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.44.3

x